#EXP00004

General

Accession EXP00004
Activity Formation (3-24h)
Date 2013-11-08
Administration In solution
Model in vitro
Organism Stenotrophomonas maltophilia
Status Validated
Notes Sm143 clinical isolate

Peptide

BMAP-27

GRFKRFRKKFKKLFKKLSPVIPLLHL

Experimental activity

Method Concentration Notes
Crystal violet assay 1.241 uM No notes
Crystal violet assay 0.62 uM No notes

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814